What is it?

PuraPly Antimicrobial consists of a native, cross-linked ECM plus 0.1% polyhexamethylene biguanide hydrochloride (PHMB) intended for the management of wounds, and as an effective barrier to control bioburden and prevent biofilm re-formation.1-3

Wound types & intended use

PuraPly Antimicrobial Wound Matrix is indicated for the management of:

  • Partial and full-thickness wounds
  • Pressure ulcers
  • Venous ulcers
  • Diabetic ulcers
  • Chronic vascular ulcers
  • Tunneled/undermined wounds
  • Surgical wounds
  • Trauma wounds
  • Draining wounds
Why PuraPly AM?

Unlike sterile dressings and placental allografts, only PuraPly AM combines native, cross-linked ECM and broad-spectrum PHMB to provide a sustained antimicrobial barrier.3,4


References:
  1. Hubner NO, et al. Skin Pharmacol Physiol. 2010;23(suppl):17-27.
  2. Brantley J, et al. Wounds Int. 2016;7(3):1-5
  3. Data on file. PDR-0001. Organogenesis Inc.
  4. Data on file. PDR-0002. Organogenesis Inc.

PuraPly® AM News

See Related News Articles

Contact us for more information about Organogenesis Surgical & Sports Medicine products